Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for NALTREXONE
- Efficacy of Baclofen Vs Naltrexon in Achieving & Maintaining Abstinence in Alcohol Dependence.
- Naltrexone for Prolonged Grief Disorder
- Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)
- Oral Buprenorphine as a Novel Low-dose Induction Strategy for Opioid Use Disorder
- Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal
- Naltrexone and Propranolol Combined With Immunotherapy
- Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)
- Emergency Department-Initiated Medications for Alcohol Use Disorder
- Sublingual Dexmedetomidine for Treating Opioid Withdrawal
- Naltrexone and Acetaminophen Combination and Its Components in Adult Acute Migraine (AT-06)
- Novel Induction to Buprenorphine/Naloxone
- A Clinical Trial to Assess Pharmacokinetic Profiles and Safety of IVL3004
- Open Label Comparison of Injectable Buprenorphine ( Brixadi®) and Naltrexone (Vivitrol®) for Opioid Use Disorder
- Evaluate the Safety and Pharmacokinetic Profile of ETR028 and ETR029 in Healthy Adult Subjects
- Treatment of Withdrawal Symptoms and Prevention of Relapse in Patients With Tramadol Abuse
- NAlmefene Versus Placebo in Addition to Treatment as Usual on Craving in Behavioural Addictions
- Low Dose Naltrexone for Pain in Patients With HIV
- Evaluating Buspirone to Treat Opioid Withdrawal
- Naltrexone Neuroimaging Randomized Controlled Trial
- Lemborexant Augmentation of Naltrexone for Alcohol Craving and Sleep
- Low-dose Naltrexone for Post-COVID Fatigue Syndrome
- A Phase II Study of the O'Neil Long Acting Naltrexone Implant in Opioid Dependent Persons
- Low Dose Naltrexone Use in Patients With POTS
- Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2)
- Bridging ED to Outpatient AUD Therapy With Naltrexone
- Pharmacological and Behavioral Treatment After Bariatric Surgery
- Oxytocin and Naltrexone: Investigation of Combined Effects on Stress- and Alcohol Cue-induced Craving in Alcohol Use Disorder
- Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat
- In Hospital IM Naltrexone: A Pilot Study
- Oral Naltrexone In Pediatric Eating Disorders
- Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder
- Effects of Naltrexone on Nocturnal Breathing Patterns at Altitude
- Naltrexone in AUD Reward Drinkers
- Assessing a Clinically-meaningful Opioid Withdrawal Phenotype
- Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder
- Understanding How Opioids Affect the Experiential and Neural Signatures of Social Experiences
- Study to Evaluate the Pharmacokinetics of SP-104
- Glutamate and Opioid Mechanisms of Antidepressant Response to Ketamine
- A Study of NAC for AUD
- Study to Evaluate the Safety of SP-104
- Naltrexone Neuroimaging
- Use of Mysimba in Patients With Weight Regain After Bariatric Surgery
- Opioid Modulation and Neural Reward Activation in Healthy Adults
- Pharmacokinetic and Safety Study of Naltrexone Release From Subcutaneous BICX104 Pellets Compared to Vivitrol Injections
- ED Initiated Oral Naltrexone for AUD
- Intermittent Oral Naltrexone Enhanced With an Ecological Momentary Intervention for Methamphetamine-using MSM
- An Investigation of the Effects of Opioid Receptor Blockade on Changes in Self-esteem and Social Attention
- Impact of Colchicine and Low-dose Naltrexone on COVID-19
- Cost-utility and Physiological Effects of LDN in Patients With Fibromyalgia
- RCT for Gambling and Naltrexone, Using Use Eye-tracking Analysis to Predict Treatment Response
- Pharmacokinetic Study of Vivitrol in Healthy Participants
- Phase 2 Trial to Evaluate Safety and Efficacy of CYTO-205 in Mild COVID-19
- Low-Dose Naltrexone for the Treatment of Painful Diabetic Neuropathy
- Psychobiological Mechanisms Underlying Chronic Pain
- Predicting Response to Naltrexone With Eye Tracking in Videogame Disorder
- Evaluation of the Efficacy of Sodium Oxybate in the Long-term Maintenance of Abstinence in Alcoholic Patients
- Comparing a Virtual vs. Face to Face Weight Management Program Using Phentermine for Patients With Overweight or Obesity
- Pharmacological and Behavioral Treatments After Bariatric Surgery: Maintenance Treatment (Stage 2a)
- Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome
- Pilot Study Into the Use of Metformin and LDN for Patients With COVID-19
- Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)
- Evaluating Contrave for Weight Maintenance in Adults With BMI >= 27 Kg/m2, After 6 Month Behaviour Modification Program.
- A Trial Evaluating the Effectiveness of Contrave in Patients Who Have Weight Recidivism Following Bariatric Surgery
- CBT-I Augmentation of TOP for Sobriety and Insomnia in AUD
- Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
- Inpatient Single Dose Interventions for Alcohol Use Disorder
- Relapse Prevention in Stimulant Use Disorder
- Naltrexone Treatment for Prolonged Grief Disorder (PGD)
- LDN and tDCS in Fibromyalgia
- Adaptive Nutrition and Exercise Weight Loss (A-NEW) Study
- Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
- Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)
- Clinical Trials of Multivalent Opioid Vaccine Components
- Brain Mechanisms of Pharmacotherapy in Opioid Use Disorder
- Low-dose Naltrexone for Bladder Pain Syndrome
- Oral Low-Dose Naltrexone for Lichen Planopilaris and Frontal Fibrosing Alopecia
- Extended Release Naltrexone Versus Extended Release Buprenorphine With Individuals Leaving Jail
- Naltrexone/Bupropion (Mysimba) to Optimize Weight Outcomes After Obesity Surgery
- Effect of Naltrexone in Achieving and Maintaining Abstinence From Alcohol in Patients With Cirrhosis.
- Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19
- EXHIT ENTRE Comparative Effectiveness Trial
- Treatment of Chronic Itch in Atopic Dermatitis With Opioid Antagonist Naltrexone
- An Innovative Intervention for OUD Treatment
- Study of Naltrexone-Induced Blockade of Antidepressant Effects
- IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone
- Examining the Role of the Orexin System in Sleep and Stress in Persons With Opioid Use Disorder
- Rapid Antidepressant Improvement Secondary to Excitatory Brain Responses
- Fibromyalgia and Naltrexone: The FINAL Study
- Efficacy of Low Dose Naltrexone in Psoriasis
- A Novel Human Lab Model for Screening AUD Medications
- Long-acting Buprenorphine vs. Naltrexone Opioid Treatments in CJS-involved Adults
- Combining Pregabalin (LYRICA®) With Lofexidine (LUCEMYRATM) to Treat OPIOID Withdrawal
- Cannabidiol Use to Reduce Cravings in Individuals With Opioid Use Disorder on Buprenorphine
- Opioids and Social Support Enhanced Extinction Effects
- Treatment of Chronic Itch in Atopic Dermatitis With Topical Naltrexone
- Vivitrol Treatment for Cannabis Use Disorder
- Low Dose Naltrexone for Chronic Pain in Osteoarthritis and Inflammatory Arthritis
- Dutasteride Treatment for Reducing Heavy Drinking in AUD: Predictors of Efficacy
- Feasibility of Emergency Department Initiated Extended-Release Naltrexone for the Treatment of Alcohol Use Disorder
- Lofexidine for Management of Opioid Withdrawal With XR-NTX Treatment
- St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Gabapentin
- Low-Dose Naltrexone in Combination With Standard Treatment in Women With Endometriosis
- Randomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.
- Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Medication Change for Non-Responders
- Rapid Initiation of Drug Treatment Engagement
- The Evaluation of Safety and Tolerance of Commercially Available Naltrexone Administered Daily - Assessment for CBRN Operations
- Study of the Opioid Modulation of the Effect of Alcohol on the Dopaminergic Reward System
- Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD
- Evaluation of Intranasal Naltrexone and Naloxone
- OLANI PK/Safety Study in Healthy Volunteers
- Study for Naltrexone on the Abuse Potential of Methylphenidate
- Medication Maintenance Therapy in Community Pharmacy Settings
- Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals
- Comparison of Three Opioid Detoxification Treatment Regimens
- Effect of Topical Naltrexone Ophthalmic Solution on the Signs and Symptoms of Dry Eye in Diabetic Subjects
- Long Acting Naltrexone for Opioid Addiction: Focus on Sustained Abstinence and Recovery
- Effects of Mediterranean Diet and Naltrexone/Bupropion Treatment in Obese Breast Cancer Patients
- Efficacy and Mechanisms of Naltrexone+Bupropion for Binge Eating Disorder
- Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis
- Defining the Clinical Role of Topiramate in the Treatment of Alcohol Dependence in Australia
- Endogenous Modulation and Central Sensitization in New Daily Persistent Headache ( NDPH ) in Children
- Re-entry XR-NTX for Rural Individuals With Opioid Use Disorder
- Assessment of and Treatment Applied to Food Addiction in a Rural Healthy Behaviors Clinic
- The Safety and Efficacy of Naltrexone and Scopolamine Utilized in the Treatment of Major Depression
- Facilitating Rapid Naltrexone Initiation
- Linking Infectious and Narcology Care-Part II
- St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Nalmefene
- Comparing Treatments for HIV-Infected Opioid Users in an Integrated Care Effectiveness Study (CHOICES) Scale-Up
- A Strategy to Improve Success of Treatment Discontinuation in Buprenorphine Responders
- Pharmacogenetics of Naltrexone for Stimulant Abuse
- Low-Dose Naltrexone and Acetaminophen Combination in the Treatment of Chronic Low Back Pain (ANODYNE-4)
- The Preventive Treatment of Migraine With Low-Dose Naltrexone and Acetaminophen Combination
- Brain Dopaminergic Signaling in Opioid Use Disorders
- Low-Dose Naltrexone and Acetaminophen Combination and Sumatriptan in the Acute Treatment of Migraine With Nausea
- Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use Disorder
- Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)
- Naltrexone-Bupropion Versus Placebo-Bupropion for Weight Loss in Schizophrenia
- Buprenorphine as Adjunct to Outpatient Induction Onto Vivitrol
- Hepatitis C Treatment in PWIDs: MAT or Syringe Exchange Assisted-therapy vs Standard of Care
- Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings
- Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder
- Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Specialist Treatment
- Low-Dose Naltrexone and Acetaminophen Combination and Its Components in the Acute Treatment of Migraine
- Fixed Dose Combination of Fluoxetin and Metformin in the Management of Overweight and Obesity
- Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Maintenance Therapy
- Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Acute Treatment
- Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A
- Low Dose Naltrexone for Chronic Pain From Arthritis
- Feasibility Study of Extended-release Naltrexone (Vivitrol) in Drug Court Settings
- Effect of High-dose Naloxone Following Third Molar Extraction
- Immune Effects of Low-dose Naltrexone in ME/CFS
- Evaluation of Nalmefene in Impulse Control Disorders in Parkinson's Disease: A Prospective Open Label Study
- Double-Blind Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression (TRD)
- Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home
- Long-acting Naltrexone for Pre-release Prisoners
- An Open Label Trial of Bupropion and Naltrexone for Binge Drinking
- An fMRI Study of Opioid-related Changes in Neural Activity
- Low Dose Naltrexone for Treatment of Pain in Patients With Fibromyalgia - Effect Via a Central Mechanism?
- The Impact of the Opiate Antagonist Naltrexone on the Emotional Valence of Dreams
- Study to Assess Pharmacokinetic (PK), Bioavailability & Food Effect of MR902 Compared With Immediate Release (IR) Morphine Sulphate Oral Solution
- Treatment for Alcohol Dependence With Gabapentin
- Pharmacokinetic Evaluation of Intranasal, Intramuscular, and Oral Naltrexone in Healthy Volunteers
- Study to Evaluate the Effect of Naltrexone and Bupropion Combination on the Pharmacokinetics of Metformin in Healthy Participants
- Naltrexone and Bupropion Combination on Obese,Smoking Patients With Schizophrenia
- Study to Evaluate the Effect of Naltrexone and Bupropion Extended-Release Combination on Cardiac Repolarization in Healthy Participants
- Evaluation of Naltrexone as a Treatment for Self-injurious Behavior
- Combining Varenicline and Naltrexone for Smoking Cessation
- Evaluating Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Transitioning From Buprenorphine Maintenance Prior to First Dose of VIVITROL
- Adaptive Treatment for Alcohol and Cocaine Dependence
- Effect of High-dose Target-controlled Naloxone Infusion on Pain and Hyperalgesia During a Burn Injury
- Safety and Pharmacokinetic Study of ALO-02 in Children Ages 7-17 With Pain
- Validation of a Test System for Development of Medications for Alcoholism
- Naltrexone/Bupropion Cardiovascular Outcomes Study
- Outcomes of Opioid Addicted Prisoners With Extended-Release Injectable Naltrexone
- Efficacy of Naltrexone HCl/Bupropion HCl Extended Release Versus Placebo for Treatment of Weight Regain in Participants Post Bariatric Surgery
- Medication-Assisted Treatment for Youth With Substance Use Disorders
- Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
- Study of Methylnaltrexone in Opioid-Induced Constipation Patients
- Dopamine and Opioid Receptor Antagonists Reduce Cue-induced Reward Responding and Reward Impulsivity
- Improving Treatment Outcomes for Prescription Opioid Dependence
- Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)
- The Effect of Regular Naltrexone Dosing on Disordered Gamblers
- Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome
- Alcohol Disorder hOsPital Treatment Trial
- Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder
- Study of PF614 Compared to OxyContin® in Healthy Volunteers
- Assessment of the Effect of Naltrexone on Lofexidine Single Dose Pharmacokinetics in Healthy Subjects
- Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users
- Glutamatergic Modulation to Facilitate Naltrexone Initiation in Opioid Dependence
- A Study to Evaluate Safety and Efficacy Following Dosing of Oxycodone/Naltrexone for Treatment of Adults With Pain Following Bunionectomy Surgery
- A Study to Evaluate Withdrawal Effects Following Dosing of Oxycodone/Naltrexone in Methadone-Maintained Subjects
- The Comparison of Stress Response to Rapid Opioid Detoxification Applying Different Methods of Opioid Antagonism
- Efficacy of Naloxone in Reducing Postictal Central Respiratory Dysfunction in Patients With Epilepsy
- Say When: Targeting Heavy Alcohol Use With Naltrexone Among MSM
- Biomarkers of Injectable Extended Release Naltrexone Treatment
- Prazosin and Naltrexone (PaN) Study for Veterans With Alcohol Use Disorders
- Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo
- Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone
- Treatment of Chronic Itch in Atopic Dermatitis (Eczema)
- Bioequivalence Study Comparing Naltrexone SR/Bupropion SR Trilayer Tablets From Two Manufacturers
- Trial of Naltrexone and Dextromethorphan for Gulf War Illness
- An Adherence Tool to Manage Narcotic -Addicted HIV Patients
- Effects of Ethanol on Oxycodone Pharmacokinetics in Healthy Volunteers
- Exploratory Bioavailability of Fentanyl Sublingual Spray Under Fasting Conditions
- Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer
- Injectable Pharmacotherapy for Opioid Use Disorders (IPOD)
- Low Dose Naltrexone (LDN) Immune Monitoring
- Safety and Pharmacokinetic Study of EMBEDA in Children Ages 7-17 With Pain
- Study of Long-Acting Injectable Naltrexone to Treat Cannabis Dependence
- Adherence to HIV Therapy in Heroin Addicts: Oral vs XR-NTX
- Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment
- Naltrexone for Individuals of East Asian Descent
- Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry
- The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) at Doses up to 80 Micrograms/Hour (mcg/hr) and Naltrexone on Electrocardiogram (ECG) Intervals in Healthy Volunteers
- Control of Cognition (Naltrexone, Methylphenidate, and ADHD Study (NMAS))
- Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder
- Efficacy and Safety of High Dose Baclofen for Alcohol Dependence
- Targeting GABA and Opioid Systems for a Pharmacotherapy for Methamphetamine Abuse
- Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate
- Harm Reduction With Pharmacotherapy (HaRP)
- Food Effect And Relative Bioavailability Study Of Oxycodone in Healthy Volunteers
- Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study
- Improving Buprenorphine Detoxification Outcomes With Isradipine
- Nalrexone Facilitated Discontinuation of Buprenorphine
- Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary Care
- Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone
- Low-Dose Naltrexone (LDN) for Depression Relapse and Recurrence
- An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.
- Naltrexone for Antipsychotic-Induced Weight Gain
- Oral vs. Injectable Naltrexone for Hospitalized Veterans With Alcohol Dependence
- Extended Release Naltrexone for Opioid-Dependent Youth
- A Study to Characterize the Abuse Liability of Intravenous Oxycodone Alone or in Combination With Intravenous Naltrexone in Healthy, Non-Dependent, Recreational Opioid Users
- A Pharmacokinetic and Safety Study of Osmotic Release Oral System (OROS) Hydromorphone in Non-Opioid Tolerant Chinese Participants With Cancer
- Risky Decision Making in Methamphetamine Users: The Role of Opioid Blockade
- Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease
- A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Users When ALO-02 Capsules Are Crushed and Snorted
- Method-of-Use Study Assessing the Effect of Naltrexone Sustained Release (SR)/ Bupropion SR on Body Weight and Cardiovascular Risk Factors in Overweight and Obese Subjects
- Pharmacokinetic Characterization of the Active, Separated System With PK Controller (Fentanyl Iontophoretic Transdermal System, 40 Mcg Fentanyl Per Activation).
- A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Abusers
- A Novel Anti-Obesity Drug Combination as a Pharmacotherapy for Cocaine Dependence
- To Evaluate the Influence of the A118G Polymorphism in the mu Opioid Receptor Gene (OPRM1) on Effects of GSK1521498 and Naltrexone on Physiological and Behavioural Markers of Brain Function in Healthy Social Drinkers
- Intermittent Naltrexone Among Polysubstance Users
- A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder
- Naltrexone vs Buprenorphine-Naloxone for Opioid Dependence in Norway
- Pharmacokinetics And Relative Bioavailability Study Of Oxycodone in Healthy Volunteers
- Low Dose Naltrexone-buprenorphine Transfer to Vivitrol Injection in Opioid Dependence
- A Randomized, Two-way, Crossover Study to Estimate the Relative Bioavailability of a Controlled-release Formulation of Oxycodone (40 mg) With Sequestered Naltrexone Compared With Immediate-release Oxycodone Tablets (20 mg) in Healthy Volunteers
- Study to Determine the Effects of Co-Administration of Alcohol on the Absorption of Oxycodone From a Proprietary Controlled-Release Formulation
- Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist
- Neuropharmacological Basis of Social Connection: The Role of Opioids
- Bioequivalence Study of Morphine Sulfate 60 mg Extended-Release Tablets Under Fasting Conditions
- Bioequivalence Study of Morphine Sulfate 60 mg Extended-Release Tablets Under Fed Conditions
- Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer
- Pharmacotherapy for Alcohol Dependence in Convicted Drinking Drivers
- Kappa-PET Imaging and Naltrexone in Alcohol Drinking Behaviors
- Clinical Trial to Reduce Drinking in Women With HIV
- Food Reward in Native American Women
- Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)
- Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans
- A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
- Pre-Release VIVITROL for Opioid Dependent Inmates
- The Effects of Treatment With Naltrexone in Alcohol and Cannabis-dependent Patients
- Buprenorphine and Methadone for Opioid-dependent Chronic Back Pain Patients
- The Separate and Combined Effects of Vivitrol and Opiate Abstinence Reinforcement in the Treatment of Opioid Dependence
- Treatment of Pathological Gambling With Naltrexone Pharmacotherapy and Brief Intervention
- Naltrexone and Memantine Effects on Alcohol Drinking Behaviors
- A Novel Pharmacotherapy for Alcoholism and Alcohol Liver Disease
- Depot Naltrexone Mechanism of Action in Heroin Dependent Patients Using fMRI and SPECT
- Effect of Naltrexone on Counterregulatory Mechanisms in Hypoglycemia
- Healthy Volunteers Study to Estimate the Effects of Food on the Bioavailability of Oxycodone and Naltrexone/6- Β -Naltrexol From a Extended Release Formulation of Oxycodone With Sequestered Naltrexone
- Extended-Release Naltrexone to Treat Methamphetamine Dependence in Men Who Have Sex With Men (MSM)
- Doxazosin an a1 Antagonist for Alcohol Dependence
- Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain
- Naltrexone and Clonidine Combination (ATNC05) in the Treatment of Chronic Back Pain
- Cocaine Use Reduction With Buprenorphine
- Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia
- Improved Strategies for Outpatient Opioid Detoxification
- Naltrexone for Medication Compliance Among HIV-infected Men With Alcohol Use Disorder
- Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study
- A Gene by Medication Interaction to the Acute Effects of Alcohol
- Treatment Strategy for Alcohol Use Disorders in Veterans With TBI
- Role of the Endogenous Opioid System Underlying Modulation of Experimental Pain
- A Study to Assess the Pharmacokinetics of the Hydrocodone Extended-Release Tablet (CEP-33237) in Subjects With Normal Renal Function and Subjects With Varying Degrees of Renal Impairment
- Effects of Sulfasalazine on BOLD Response to Alcohol Cues
- Low Dose Naltrexone for Glioma Patients
- Sweet Preference and Alcohol Craving
- Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
- Will Having Alcohol Treatment Improve Functioning?
- Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention
- ALK21-006: Long-Term Study of Medisorb® Naltrexone (VIVITROL®)
- ALK21-004: Single-dose Opiate Challenge of Medisorb® Naltrexone (VIVITROL®) in Adults Who Use Opioids
- ALK21-003EXT: An Extension of Study ALK21-003 (NCT01218958) to Test the Long-term Safety of Medisorb® Naltrexone (VIVITROL®)
- ALK21-003: Study of Medisorb® Naltrexone (VIVITROL®) in Alcohol-Dependent Adults
- N-acetylcysteine Plus Naltrexone for the Treatment of Alcohol Dependence
- Effects of Omegas 3 and 6 on Alcohol Dependence
- Bioequivalency Study of Oxymorphone Hydrochloride 10 mg Tablets Under Fasted Conditions
- Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
- Conversion to Embeda With Rescue Trial
- Stress, Hormones, and Eating
- Effectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+
- Pilot Study of Depot NTX in Homeless Veterans
- Naltrexone in the Treatment of Dissociative Symptoms in Patients With Borderline Personality Disorder
- Medication and Counseling for Controlled Drinking
- Adherence to HIV Therapy in Heroin Addicts: Oral vs XR-NTX
- Extended Release Naltrexone for Treating Amphetamine Dependence in Iceland
- Alcohol Pharmacotherapy for HIV+ Prisoners
- Investigation of Naltrexone for Pathological Gambling
- Naltrexone and Hypoglycemia in Type 1 Diabetes
- Naltrexone for Impulse Control Disorders in Parkinson's Disease
- Dronabinol Naltrexone Treatment for Opioid Dependence
- Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent Adolescents
- Bioequivalency Study of Buprenorphine Hydrochloride 8 mg Tablet Under Fasted Conditions
- Pilot Study of the Effects of the Desipramine on the Neurovegetative Parameters of the Child With Rett Syndrome
- Study of Naltrexone for Methamphetamine Addiction
- Efficacy of Extended Release Tramadol for Treating Prescription Opioid Withdrawal
- [11C]Carfentanil PET Study of GSK1521498
- Naltrexone for At-Risk and Problem Drinking in Smoking Cessation Treatment
- Genetic and Brain Mechanisms of Naltrexone's Treatment Efficacy for Alcoholism
- Low Dose Naltrexone for the Treatment of Juvenile Primary Fibromyalgia Syndrome
- Pharmacotherapy for HIV Infected Patients With Alcohol Problems
- ALK21-021: A Safety Study of Medisorb® Naltrexone (VIVITROL®) Administered to Health Care Professionals
- Pharmacogenetic Response to Naltrexone For Alcohol Dependence
- Understanding Treatment Response With Naltrexone Among White Alcoholics
- Pilot Trial of Naltrexone for Obesity in Women With Schizophrenia
- Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt Site
- VIVITROL as a Treatment for Cocaine and Alcohol Dependence
- Naltrexone in the Treatment of Trichotillomania
- The Effect of Naltrexone and Varenicline on Alcohol-Mediated Smoking Lapse
- Combining Medications for the Treatment of Alcohol Dependence: An Inpatient Preliminary Study
- Combined Pharmacotherapies for Alcoholism
- Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder
- Depot Naltrexone Treatment of Opioid Dependent Parolees
- Study to Determine the Bioavailability, Pharmacodynamic Effects, and Safety of Whole and Crushed ALO-01 Compared to Morphine Sulfate Immediate Release (MSIR)
- A New Pharmacotherapy for Alcohol Dependence: Olanzapine
- Effects of Low-dose Naltrexone in Combination With a Range of Smoked Marijuana
- Study to Evaluate the Subjective Effects of PTI-801 in Non-Physically Dependent Subjects With a History of Drug Abuse
- Buprenorphine Naltrexone-P1 A-Cocaine
- Effective Treatment for Prescription Opioid Abuse
- The Efficacy of Low Dose Naltrexone Therapy in Children With Crohn's Disease
- Pharmacokinetics of Naltrexone Following Intravenous and Oral Routes of Administration in Healthy Volunteers
- Pharmacokinetics of Fentanyl Following Intravenous and Oral Routes of Administration in Healthy Volunteers
- A Study Using Functional Magnetic Resonance Imaging (fMRI) to Assess the Effects of Naltrexone SR/ Bupropion SR Therapy in Overweight or Obese Subjects
- ALK21-013: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) in Adults With Opioid Dependence
- Effectiveness of Alcohol Interventions Among Tuberculosis (TB) Patients in Tomsk Oblast, Russia
- An Exploratory Study of Naltrexone Plus Aripiprazole for Alcohol Dependence
- The Effect of Naltrexone on Alcohol Craving and on Brain Activity During Alcohol Infusion
- The Effects of Naltrexone on Active Crohn's Disease
- Medication Development in Alcoholism: Acamprosate Versus Naltrexone
- Safety of Acamprosate for Alcohol Dependence in the Elderly: An Open-Label Study (SAFADIE)
- A Study to Evaluate the Safety of D-TRANS Fentanyl With Naltrexone in Adult Patients With Chronic Pain and Who Are Opioid Tolerant
- A Study of Naltrexone SR/ Bupropion SR in Overweight or Obese Subjects With Major Depression
- Extended-release Naltrexone for Alcohol Dependence in Primary Care
- Combination of Naltrexone and Baclofen for Alcohol Dependence:A Pilot Study.
- Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone
- Naltrexone for Heavy Drinking in Young Adults
- Effects of Low Dose Naltrexone in Fibromyalgia
- A Safety and Efficacy Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects
- Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-Effects
- A Study of Naltrexone SR/ Bupropion SR in Overweight and Obese Subjects Who Are Nicotine-Dependent
- Quetiapine vs. Placebo in Alcohol Relapse Prevention - a Pilot Study
- A Study of the Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects
- Research on Individualized Treatment for Alcoholism
- Naltrexone Implants as an Aid in Preventing Relapse Following Inpatient Treatment for Opioid Addiction
- ALK21-018: Effects of Medisorb® Naltrexone (VIVITROL®) on Alcohol Craving in Treatment-seeking, Alcohol-dependent Adults
- Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic Disease
- Naltrexone and Varenicline: Weight Gain and Tolerability in Cigarette Smokers
- A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone
- ALK21-014: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) After Enforced Abstinence
- Memantine as a Supplement to Naltrexone in Treating Heroin Dependence
- A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes
- Double-Blind Naltrexone in Compulsive Sexual Behavior
- Naltrexone in the Treatment of Pyromania
- Long-Acting Injectable Naltrexone Treatment of Alcohol Dependence in Primary Care vs. in Specialized Chemical Dependence Treatment: A Pilot Trial
- A Safety and Efficacy Study of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects Participating in an Intensive Behavior Modification Program
- Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI)
- Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI)
- Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and Alcoholism
- Medication and Counseling for Controlled Drinking (Project SMART)
- Substance Abuse Pre-Treatment Screening Study
- Comparative Trial Of Disulfiram, Naltrexone And Acamprosate In The Treatment Of Alcohol Dependence
- A Study of Embeda (Kadian NT, ALO-01) in Subjects With Pain Due to Osteoarthritis of the Hip or Knee
- Study of Bupropion Versus Bupropion + Naltrexone for Smoking Cessation
- Study of Embeda (Kadian NT, ALO-01) in Subjects With Chronic Moderate to Severe Nonmalignant Pain
- Effects of a Range of Naltrexone Doses in Combination With Smoked Marijuana
- An Open-Label Evaluation of the Independent Effects of Coadministration of a High-Fat Meal and Naltrexone Blockade on the Pharmacokinetic Profile of Dilaudid OROS (Hydromorphone HCI) 16mg
- An Open-Label Evaluation of the Dose Proportionality of OROS� Hydromorphone HCL Tablets 8mg, 16mg, 32mg, 64mg
- HIV Risk Reduction and Drug Abuse Treatment in Iran
- HIV Risk Reduction and Drug Abuse Treatment in Malaysia
- Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer
- Comparison Between Marijuana Smoked in Cigarette Paper Versus Cigar Paper
- Targeted Naltrexone for Problem Drinkers
- Effectiveness of Naltrexone Versus Placebo to Reduce Craving for Alcohol With Evaluation of Genetic Variability.
- Efficacy and Safety Study of Combination Therapy to Treat Uncomplicated Obesity
- Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients
- Naltrexone & SSRI in Alcoholics With Depression/PTSD
- N-Acetyl Cysteine Plus Naltrexone in Methamphetamine Dependence
- Double-Blind Naltrexone in Kleptomania
- Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence
- The Effects of Topiramate on Alcohol Use in Alcohol Dependent Subjects
- Naltrexone in the Treatment of Concurrent Alcohol Dependence and Pathological Gambling
- Trial of Low-Dose Naltrexone for Children With Pervasive Developmental Disorder (PDD)
- Individually Adapted Therapy of Alcoholism
- Optimizing Pharmacotherapy for Bipolar Alcoholics
- Assessment of Tramadol as a Treatment for Opioid Addiction
- Efficacy of Naltrexone in Women's Smoking Cessation
- Effects of Naltrexone on Nicotine Reinforcement
- Naltrexone Implants as Relapse Prevention
- Treatment of Patients With Alcoholism and Attention Deficit Disorder
- Endophenotype for Alcohol Misuse in Healthy Minority Populations
- Naltrexone Effects on Alcohol Intake
- A Placebo-Controlled Trial of Memantine for Alcohol Dependence
- Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1
- Efficacy of Naltrexone Treatment as Augmentation to SSRI in OCD Patients
- Naltrexone for Bipolar Disorder and Alcohol Dependence
- Naltrexone in Two Models of Psychosocial Treatments for Cocaine and Alcohol Dependence - 1
- Combined Treatment for Cocaine-Alcohol Dependence - 1
- Effectiveness of Naltrexone and Lofexidine in Treating Detoxified Heroin Addicts - 1
- Addiction Treatment in Russia: Oral vs. Naltrexone Implant
- Naltrexone Augmentation of Nicotine Patch Therapy - 1
- Medications for Stopping Cocaine Dependence and Preventing Relapse
- Abilify Therapy for Reducing Comorbid Substance Abuse
- Naltrexone Implants vs. MMT Among Inmates in the Norwegian Correctional Services
- Effectiveness of Naltrexone and/or Ondansetron to Reduce Craving for Alcohol and Drinking
- Effectiveness of Gabapentin When Used With Naltrexone to Treat Alcohol Dependence Compared to Placebo and Naltrexone Alone
- Science-Based Treatment for Opioid-Dependent Adolescents
- Naltrexone in Two Models of Psychosocial Treatments for Cocaine and Alcohol Dependence
- ALK21-006EXT: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol- or Opioid-dependent Adults (Extension of Study ALK21-006 [NCT01218997])
- ALK21-010: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol-dependent Adults
- Study To Examine Effect Of CP-866,087 On Consumption And Craving Of Alcohol In Alcohol Dependent Subjects.
- Naltrexone Treatment of Alcohol Abuse in Schizophrenia
- Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin Addicts
- Effectiveness of Lofexidine to Prevent Stress-Related Opiate Relapse During Naltrexone Treatment - 1
- Combination of Disulfiram Plus Naltrexone to Treat Both Cocaine- and Alcohol-dependent Individuals - 1
- Modafinil and Naltrexone to Reduce Cocaine and Alcohol Dependence
- Addition of Naltrexone to Methadone Taper
- Low-Dose Naltrexone Combined With Bupropion to Stop Smoking With Less Weight Gain
- Memantine and Naltrexone Treatment for Opioid Dependence
- Naltrexone in Borderline Personality Disorder
- Trial for the Treatment of Alcohol Dependence
- Managing Alcoholism in People Who Do Not Respond to Naltrexone
- Targeted Interventions for Weight-Concerned Smokers
- Self-Injury: Diagnosis and Treatment
- Drug Treatment for Pathologic Gambling Disorder
- Effects of Yohimbine and Naltrexone on Sexual Function
- Combined Pharmacotherapies for Alcoholism (Naltrexone/Ondansetron)
- Treating Alcohol Use In Older Adults With Depression
- Naltrexone and Patch for Smokers
- Naltrexone in Treatment of Cocaine Dependence - 5
- Treatment for Alcoholism and Post-Traumatic Stress Disorder (Naltrexone)
- Post-Treatment Effects of Naltrexone
- COMBINE (Acamprosate/Naltrexone)
- Drug Treatment for Depressed Alcoholics (Naltrexone/Fluoxetine)
- Naltrexone, Craving, and Drinking
- Sertraline for Alcohol Dependence and Depression
- Behavioral Therapy Plus Naltrexone for Alcoholism
- Naltrexone for Early Problem Drinkers
- Naltrexone Treatment of Alcohol Dependence
- Drug Therapy for Alcohol Dependence in Alaska Natives (Naltrexone/Sertraline)
- Naltrexone Maintenance Treatment of Alcoholism
- Behavior and Naltrexone Treatment for Alcoholics
- Naltrexone Treatment for Alcoholic Women
- Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (Naltrexone/Nicotine Patch)
- Use of Naltrexone in a Clinical Setting
- Naltrexone for Relapse Prevention
- Sertraline and Naltrexone for Alcohol Dependence
- Naltrexone Treatment for Alcoholism
- Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone)
- Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4
- Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2
- A Laboratory Model for Heroin Abuse Medications - 8
- Buprenorphine Pharmacology Related to Addiction Treatment - 18
- Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13
- Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12
- Neurobiology of Opioid Dependence: 5 - 5
- Neurobiology of Opioid Dependence: 4 - 4
Clinical trials list
click for details